Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01491334 · ClinicalTrials.gov registry record
Validation of Transvaginal Tactile Imaging
A clinical trial of Pelvic Organ Prolapse, sponsored by Artann Laboratories.
- Completed
- Registry status
- 158
- Enrollment target
- 2
- Study locations
NCT01491334: Completed study of Pelvic Organ Prolapse, sponsored by Artann Laboratories.
NCT01491334 is a study of Pelvic Organ Prolapse that has completed, run by Artann Laboratories. The registered enrollment target is 158 participants, above the 141-participant average among 40 other Pelvic Organ Prolapse trials with a reported enrollment target (12% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01491334, a study of Pelvic Organ Prolapse, has completed, sponsored by Artann Laboratories.
- COMPLETED
- Registry status
- 158 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to validate safety and effectiveness in assessment of the female pelvic floor tissue, and, assess the ability of Vaginal Tactile Imager (VTI) to detect early prolapse conditions and characterize the outcome of reconstructive surgery.
Conditions Studied
Study Locations (2)
New Jersey
- Princeton Urogynecology - Princeton
Pennsylvania
- Institute of Female Pelvic Medicine and Reconstructive Surgery - Allentown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 158 participants |
| Start Date | 2011-12 |
| Est. Completion | 2013-11 |
What the finished NCT01491334 record still lists
NCT01491334 is an observational study that tracks outcomes without assigning an intervention. The registered 158 participants enrollment target is mid-sized for trials with a published cap, above the 141-participant average among 40 other Pelvic Organ Prolapse trials with a reported enrollment target (12% higher).
The record links to 1 condition, with Pelvic Organ Prolapse appearing as the primary indexed condition, and to 0 interventions.
NCT01491334 reports a single indexed study location in New Jersey, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01491334 about?
NCT01491334 is a clinical study titled "Validation of Transvaginal Tactile Imaging". The purpose of this study is to validate safety and effectiveness in assessment of the female pelvic floor tissue, and, assess the ability of Vaginal Tactile Imager (VTI) to detect early prolapse conditions and characterize the outcome of reconstructive surgery.
What is the current status of trial NCT01491334?
This trial is currently completed. The enrollment target is 158 participants. The study started on 2011-12. Estimated completion is 2013-11.
What conditions does trial NCT01491334 study?
This clinical trial studies the following conditions: Pelvic Organ Prolapse.
Who is sponsoring clinical trial NCT01491334?
This trial is sponsored by Artann Laboratories, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01491334 being conducted?
This trial has 2 study locations across New Jersey, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pelvic Organ Prolapse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01491334's enrollment target sits among peer trials
158 9th of 40 higher than 32 of 40 other Pelvic Organ Prolapse trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pelvic Organ Prolapse trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Centered Surgery - Preoperative Counseling and Patient Satisfaction
RECRUITING
-
Ethicon Pelvic Mesh Post Market Clinical Follow-up Registry
RECRUITING
-
Pessary Experience Study
RECRUITING
-
SORE Study: Sitz Baths After Urogynecologic Reconstruction
RECRUITING · NA
-
POMEGRANATE Trial: Comparing Reia Pessary Versus Standard of Care Pessary for Pelvic Organ Prolapse Treatment
RECRUITING · NA
-
Sequence of Midurethral Sling Placement During Robotic Sacrocolpopexy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04486833 · 158 participants · Phase 1
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
- NCT04697966 · 158 participants · NA
Mechanisms and Predictors of Change in App-Based Mindfulness Training for Adolescents
- NCT04969835 · 158 participants · Phase 1
A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours
- NCT05230732 · 158 participants · NA
Neuromodulation of Inflammation and Endothelial Function
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia